![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
Tepha is engaged in the development of a new range of bioabsorbable medical devices for therapeutic applications. The Company has licensed and is applying a patented core technology which allows it to produce bioabsorbable polymers suitable for use in a wide range of implantable products to treat humans with defective tissues and organs.
Holds annual scientific meetings, publishes journals and newsletters, and facilitates contact among interested polymer researchers in academia, industry, and government.
This center, supported by the U.S. National Science Foundation, engages in a variety of research related to biodegradable polymer synthesis and processing.
The NIST ATP program supports high risk, high payoff research that make feasible a broad range of new commercial opportunities with a high payoff for the nation as a whole. Metabolix received a NIST ATP grant to develop a highly efficient strain for producing Mirels.
Metabolix has a grant with the Department of Energy's Office of Biomass Programs to develop a Mirels production in a Biomass Biorefinery.
The 2002 Farm Bill provided funding for Biomass Research and Development Initiatives, as well as statutory authority for USDA to designate biobased products for preferred purchasing by Government Agencies. Metabolix has a Biomass R&D grant with the Department of Agriculture's Natural Resource Conservation Service (NRCS) to produce Mirels in switchgrass.
Report of a U.S. fact finding team on various Japanese institutions involved in the production and use of biodegradable polymers.